ILC Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in ILC Therapeutics?

ILC Therapeutics has 4 investors including Medical Incubator Japan And EOS Technology Investment Syndicate.

Q: When was the last funding round for ILC Therapeutics?

ILC Therapeutics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has ILC Therapeutics raised to date?

ILC Therapeutics has raised obfuscated.

Overview

ILC Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ILC Therapeutics

CB Rank

112550

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

Founded

obfuscation

Private

Venture - Series Unknown

Newhouse, North Lanarkshire, United Kingdom

1-10

www.ilctherapeutics.com/

Biotechnology

Health Care

Life Science

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Alan Walker: Chief Executive Officer
Past Role: Ryboquin, CEO
Alistair Strachan: Co Founder, Investor

Details

Legal Name

ILC Therapeutics Ltd

Also Known As

Alfacyte

Operating Status

Active

Company Type

For Profit

Founders

Alistair Strachan, William Stimson

About the Company

ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.

Phone Number

+44 (0) 7403 554048

Contact Email

contact@ilctherapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

ILC Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Alfacyte™

A hybrid interferon therapeutic candidate designed as a broad-spectrum antiviral to treat respiratory viral infections, including RSV and COVID-19.

Hybrid Interferon Platform

A cytokine engineering platform that designs and develops novel hybrid interferons with improved therapeutic profiles for multiple disease indications.

Research & Development

ILC Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ILC Therapeutics	4	obfuscated obfuscation	EOS Technology Investment Syndicate	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Medical Incubator Japan	—	Venture Round - ILC Therapeutics	Jun Katsura
Medical Incubator Japan	—	Venture Round - ILC Therapeutics	Jun Katsura
Medical Incubator Japan	—	Venture Round - ILC Therapeutics	Jun Katsura
Medical Incubator Japan	—	Venture Round - ILC Therapeutics	Jun Katsura
Medical Incubator Japan	—	Venture Round - ILC Therapeutics	Jun Katsura